HeartSciences Files 10-K and Announces Preliminary Proxy for Proposed Transactions

What Happened

• On July 23, 2026 HeartSciences, Inc. issued a press release announcing it filed its Annual Report on Form 10‑K for the fiscal year ended April 30, 2026 with the SEC and that it expects to file a preliminary proxy statement shortly in connection with its recently announced proposed Transactions. The press release is furnished as Exhibit 99.1 to the Form 8‑K.
• The company noted that, as previously disclosed, on June 23, 2026 it entered into an Agreement and Plan of Merger (the “Merger Agreement”) involving HeartSciences, Fortitude Mining Holdings, Inc. (Seller), Fortitude Mining HoldCo, LLC (Fortitude), and Cordis Acquisition, LLC (Merger Sub).

Key Details

• Press release date: July 23, 2026 (Exhibit 99.1 to the 8‑K).
• Annual Report filed: Form 10‑K for fiscal year ended April 30, 2026.
• Merger Agreement execution date: June 23, 2026 (parties include HeartSciences, Fortitude entities, and Merger Sub Cordis Acquisition, LLC).
• Company expects to file a preliminary proxy statement shortly in connection with the proposed Transactions.

Why It Matters

• The filed Form 10‑K provides investors access to HeartSciences’ annual disclosures and full-year information (financials, risk factors, governance) for the year ended April 30, 2026.
• The upcoming preliminary proxy filing and the June 23, 2026 Merger Agreement indicate a formal shareholder vote or approval process is likely required for the proposed Transactions, which could materially affect the company’s ownership or strategy.
• Investors should watch for the preliminary proxy and subsequent proxy materials for transaction terms, potential impacts on revenue, leadership, and capital structure.